<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="melas" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">melas</book-part-id>
      <title-group>
        <title>MELAS</title>
        <alt-title alt-title-type="alt-title">Synonyms: Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes; Myopathy, Mitochondrial-Encephalopathy-Lactic Acidosis-Stroke</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>DiMauro</surname>
            <given-names>Salvatore</given-names>
          </name>
          <degrees>MD</degrees>
          <email>sd12@columbia.edu</email>
          <aff>Department of Neurology<break/>Columbia University <break/>New York, New York</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hirano</surname>
            <given-names>Michio</given-names>
          </name>
          <degrees>MD</degrees>
          <email>mh29@columbia.edu</email>
          <aff>Department of Neurology <break/>Columbia University <break/>New York, New York</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2001-02-27" date-type="created">
          <day>27</day>
          <month>2</month>
          <year>2001</year>
        </date>
        <date iso-8601-date="2013-11-21" date-type="updated">
          <day>21</day>
          <month>11</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="megdel" document-type="chapter">MEGDEL Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object>
      <abstract id="melas.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>MELAS (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">e</italic>ncephalomyopathy, <italic toggle="yes">l</italic>actic <italic toggle="yes">a</italic>cidosis, and <italic toggle="yes">s</italic>troke-like episodes) is a multisystem disorder with onset typically in childhood. Early psychomotor development is usually normal, but short stature is common. Onset of symptoms is frequently between the ages of two and ten years. The most common initial symptoms are generalized tonic-clonic seizures, recurrent headaches, anorexia, and recurrent vomiting. Exercise intolerance or proximal limb weakness can be the initial manifestation. Seizures are often associated with stroke-like episodes of transient hemiparesis or cortical blindness. These stroke-like episodes may be associated with altered consciousness and may be recurrent. The cumulative residual effects of the stroke-like episodes gradually impair motor abilities, vision, and mentation, often by adolescence or young adulthood. Sensorineural hearing loss is common.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of MELAS is based on a combination of clinical findings and molecular genetic testing. Pathogenic variants in the mitochondrial DNA (mtDNA) gene <italic toggle="yes">MT-TL1</italic> encoding tRNA<sup>Leu(UUA/UUG)</sup> are causative. The most common pathogenic variant, present in about 80% of individuals with typical clinical findings, is an A-to-G transition at nucleotide 3243 (m.3243A&#x0003e;G). Pathogenic variants in <italic toggle="yes">MT-TL1</italic> or other mtDNA genes, particularly <italic toggle="yes">MT-ND5</italic>, can also cause this disorder. Pathogenic variants can usually be detected in mtDNA from leukocytes in individuals with typical MELAS; however, the occurrence of "heteroplasmy" in disorders of mtDNA can result in varying tissue distribution of mutated mtDNA. Hence, the pathogenic variant may be undetectable in mtDNA from leukocytes and may be detected only in other tissues, such as cultured skin fibroblasts, hair follicles, urinary sediment, or (most reliably) skeletal muscle.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> No specific treatment for MELAS exists. Sensorineural hearing loss has been treated with cochlear implantation; seizures respond to traditional anticonvulsant therapy. Diabetes mellitus is managed by dietary modification, oral hypoglycemic agents, or insulin therapy. L-arginine showed promise in treating stroke-like episodes. Migraine headaches and cardiac manifestations are treated in the usual manner.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Coenzyme Q<sub>10</sub> and its analog, idebenone, have been beneficial in some individuals.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Because febrile illnesses may trigger acute exacerbations, individuals with MELAS should receive standard childhood vaccinations, flu vaccine, and pneumococcal vaccine.</p>
          <p><italic toggle="yes">Surveillance:</italic> Affected individuals and their at-risk relatives should be followed at regular intervals to monitor progression and the appearance of new symptoms. Annual ophthalmologic, cardiologic (electrocardiogram and echocardiogram), and endocrinologic (fasting blood sugar and TSH) evaluations are recommended.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Mitochondrial toxins, including aminoglycoside antibiotics, linezolid, cigarettes, and alcohol; valproic acid for seizure treatment; dichloroacetate (DCA) because of increased risk for peripheral neuropathy.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Affected or at-risk pregnant women should be monitored for diabetes mellitus and respiratory insufficiency, which may require therapeutic interventions</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MELAS is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance. The father of a proband is not at risk of having the mtDNA pathogenic variant. The mother of a proband usually has the mtDNA pathogenic variant and may or may not have symptoms. A man with an mtDNA pathogenic variant cannot transmit the variant to any of his offspring. A woman (affected or unaffected) transmits the variant to all of her offspring. Prenatal diagnosis and preimplantation genetic diagnosis (PGD) for MELAS is possible if a mtDNA pathogenic variant has been detected in the mother. However, because the mutational load in embryonic and fetal tissues sampled (i.e., amniocytes and chorionic villi) may not correspond to that of all fetal tissues, and because the mutational load in tissues sampled prenatally may shift in utero or after birth as a result of random mitotic segregation, prediction of the phenotype from prenatal studies cannot be made with certainty.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="melas.Diagnosis">
        <title>Diagnosis</title>
        <sec id="melas.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The clinical diagnosis of MELAS (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">e</italic>ncephalomyopathy, <italic toggle="yes">l</italic>actic <italic toggle="yes">a</italic>cidosis, and <italic toggle="yes">s</italic>troke-like episodes) is based on the following features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Stroke-like episodes, typically before age 40 years</p>
            </list-item>
            <list-item>
              <p>Encephalopathy with seizures and/or dementia</p>
            </list-item>
            <list-item>
              <p>Mitochondrial myopathy, evidenced by lactic acidosis and/or ragged red fibers (RRF) on muscle biopsy</p>
            </list-item>
          </list>
          <p>To confirm the diagnosis, two of the following are also required [<xref ref-type="bibr" rid="melas.REF.hirano.1992.125">Hirano et al 1992</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Normal early psychomotor development</p>
            </list-item>
            <list-item>
              <p>Recurrent headache</p>
            </list-item>
            <list-item>
              <p>Recurrent vomiting</p>
            </list-item>
          </list>
        </sec>
        <sec id="melas.Testing">
          <title>Testing</title>
          <p><bold>Lactic acidosis both in blood and in the CSF.</bold> In individuals with MELAS, lactate concentrations are commonly elevated at rest and increase excessively after moderate exercise.</p>
          <p>Note: Other situations (unrelated to the diagnosis of MELAS) in which lactate and pyruvate can be elevated are acute neurologic events such as seizure or stroke.</p>
          <p><bold>Elevated CSF protein.</bold> The concentration of CSF protein may be elevated but rarely surpasses 100 mg/dL.</p>
          <p><bold>Brain imaging.</bold> During stroke-like episodes, brain MRI shows areas of increased T<sub>2</sub> signal, typically involving the posterior cerebrum and not conforming to the distribution of major arteries. Slow spreading of the stroke-like lesions in the weeks following the first symptoms can be documented by T<sub>2</sub>-weighted MRI [<xref ref-type="bibr" rid="melas.REF.iizuka.2003.1238">Iizuka et al 2003</xref>]. In addition, diffusion-weighted MRI shows increased apparent diffusion coefficient (ADC) in the stroke-like lesions of MELAS, in contrast to the decreased ADC seen in ischemic strokes [<xref ref-type="bibr" rid="melas.REF.kolb.2003.11">Kolb et al 2003</xref>].</p>
          <p>Basal ganglia calcifications are also sometimes seen on CT.</p>
          <p><bold>Electrocardiogram (ECG)</bold> may show evidence of cardiomyopathy, pre-excitation, or incomplete heart block.</p>
          <p><bold>Electromyography and nerve conduction studies</bold> are consistent with a myopathic process, but neuropathy may coexist. Neuropathy is relatively common (22% in a study of 32 individuals) and is predominantly axonal and sensory [<xref ref-type="bibr" rid="melas.REF.k_rpp_.2003.216">K&#x000e4;rpp&#x000e4; et al 2003</xref>, <xref ref-type="bibr" rid="melas.REF.kaufmann.2006b.746">Kaufmann et al 2006b</xref>].</p>
          <p><bold>Muscle biopsy</bold> typically shows ragged red fibers (RRF) with the modified Gomori trichrome stain or "ragged blue fibers" resulting from the hyperintense reaction with the histochemical stain for succinate dehydrogenase (SDH). Most RRFs stain positively for cytochrome <italic toggle="yes">c</italic> oxidase (COX) activity [<xref ref-type="bibr" rid="melas.REF.dimauro.1997">DiMauro &#x00026; Bonilla 1997</xref>], unlike in other mtDNA-related disorders such as Kearns-Sayre syndrome (KSS) and MERRF (myoclonic epilepsy ragged red fibers), in which RRFs do not react with the cytochrome c oxidase (COX) histochemical stain [<xref ref-type="bibr" rid="melas.REF.filosto.2007.23">Filosto et al 2007</xref>]. An additional morphologic feature that is characteristic (though not pathognomonic) of MELAS is the overabundance of mitochondria in smooth muscle and endothelial cells of intramuscular blood vessels, best revealed with the SDH stain ("strongly succinate dehydrogenase-reactive blood vessels," or SSVs) [<xref ref-type="bibr" rid="melas.REF.hasegawa.1991.601">Hasegawa et al 1991</xref>].</p>
          <p><bold>Respiratory chain studies.</bold> Biochemical analysis of respiratory chain enzymes in muscle extracts usually shows multiple partial defects, especially involving complex I and/or complex IV. However, biochemical results can also be normal.</p>
          <sec id="melas.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p>
              <bold>Genes</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold><italic toggle="yes">MT-TL1</italic>.</bold> The mitochondrial DNA (mtDNA) gene <italic toggle="yes">MT-TL1</italic> encoding tRNA leucine 1, tRNA<sup>Leu(UUA/UUG)</sup>, is the gene in which pathogenic variants are known to cause approximately 80% of cases of MELAS.</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">MT-ND5</italic>.</bold> Pathogenic variants in <italic toggle="yes">MT-ND5</italic> encoding the NADH-ubiquinone oxidoreductase subunit 5 have been reported with increasing frequency in individuals with isolated MELAS or with overlap syndromes [<xref ref-type="bibr" rid="melas.REF.dimauro.2005.222">Dimauro &#x00026; Davidzon 2005</xref>].</p>
              </list-item>
            </list>
            <p><bold>Other mtDNA genes.</bold> Pathogenic variants known to cause MELAS have been identified in other mtDNA tRNA genes including <italic toggle="yes">MT-TC,</italic>
<italic toggle="yes">MT-TK</italic>, <italic toggle="yes">MT-TV,</italic>
<italic toggle="yes">MT-TF,</italic>
<italic toggle="yes">MT-TQ</italic>, <italic toggle="yes">MT-TS1, MT-TS2</italic>, and <italic toggle="yes">MT-TW,</italic> and in the protein-encoding genes <italic toggle="yes">MT-CO1, MT-CO2, MT-CO3</italic>, <italic toggle="yes">MT-CYB</italic>, <italic toggle="yes">MT-ND1</italic>, <italic toggle="yes">MT-ND3</italic>, and <italic toggle="yes">MT-ND6</italic> (see <xref ref-type="table" rid="melas.T.summary_of_molecular_genetic_tes">Table 1</xref> and <xref ref-type="sec" rid="melas.Molecular_Genetics">Molecular Genetics</xref>)<italic toggle="yes">.</italic></p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>
                    <italic toggle="yes">MT-TL1</italic>
                  </bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p><bold>Targeted analysis for pathogenic variants.</bold> The most common pathogenic variant in MELAS, present in more than 80% of individuals with typical clinical findings, is <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> in <italic toggle="yes">MT-TL1,</italic> first described by <xref ref-type="bibr" rid="melas.REF.goto.1990.651">Goto et al [1990]</xref>. Pathogenic variants included in targeted analysis testing panels vary across laboratories and may include the <italic toggle="yes">MT-TL1</italic> pathogenic variants <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref>, <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3271T&#x0003e;C</xref>, and <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3252A&#x0003e;G</xref> as well as additional rare pathogenic variants (<xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">Table 5</xref>). Note: (1) Pathogenic variants are usually present in all tissues and can be detected in mtDNA from blood leukocytes in individuals with typical MELAS; however, the occurrence of "heteroplasmy" in disorders of mtDNA can result in varying tissue distribution of mutated mtDNA. Hence, in individuals having one or only a few symptoms consistent with MELAS or asymptomatic maternal relatives, the pathogenic variant may be undetectable in mtDNA from leukocytes and may only be detected in other tissues (e.g., cultured skin fibroblasts, hair follicles, urinary sediment, or, most reliably, skeletal muscle). Among readily accessible tissues, urinary sediment has proven the most useful for detecting the <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> variant [<xref ref-type="bibr" rid="melas.REF.mcdonnell.2004.778">McDonnell et al 2004</xref>, <xref ref-type="bibr" rid="melas.REF.shanske.2004.134">Shanske et al 2004</xref>]. (2) A muscle biopsy is recommended in the rare instance in which the <italic toggle="yes">MT-TL1</italic>
<xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> variant cannot be detected by standard techniques in mtDNA from leukocytes or urinary sediment from an individual with classic MELAS.</p>
                  </list-item>
                  <list-item>
                    <p><bold>Sequence analysis/scanning for pathogenic variants.</bold> Sequence analysis / scanning of <italic toggle="yes">MT-TL1</italic> may be an option for individuals in whom a pathogenic variant is not detected through targeted analysis.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>
                    <italic toggle="yes">MT-ND5</italic>
                  </bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p><bold>Targeted analysis</bold> for the most common <italic toggle="yes">MT-ND5</italic> pathogenic variant, <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.13513G&#x0003e;A</xref></p>
                  </list-item>
                  <list-item>
                    <p><bold>Sequence analysis</bold> of <italic toggle="yes">MT-ND5</italic></p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>
                    <italic toggle="yes">MT-TF, MT-TH, MT-TK, MT-TQ, MT-TS1, MT-TS2, MT-ND1, MT-ND6</italic>
                  </bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>
                      <bold>Sequence analysis</bold>
                    </p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Other mtDNA genes</bold>. Complete sequencing of the mitochondrial genome can be used to detect rare pathogenic variants in all genes known to cause MELAS, if clinically indicated.</p>
              </list-item>
            </list>
            <table-wrap id="melas.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in MELAS</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of MELAS Attributed to Mutation of This Gene</th>
                    <th id="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MT-TL1</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~80%<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">m.3243A&#x0003e;G<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">~7.5%<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">m.3271T&#x0003e;C<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">&#x0003c;5%<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">m.3252A&#x0003e;G<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">&#x0003c;10%<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MT-ND5</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;15%<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Only targeted variants&#x000a0;<sup>3</sup> m.13513G&#x0003e;A<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">&#x0003c;5%<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-TF</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-TH</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-TK</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MT-TQ</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Only targeted variants&#x000a0;<sup>3</sup> m.4332G&#x0003e;A<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-TS1</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-TS2</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-ND1</italic>
                      <hr/>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare<hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup><hr/></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants<hr/></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MT-ND6</italic>
                    </td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_melas.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="melas.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="melas" object-id="melas.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="melas.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="melas.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="melas.TF.1.3">
                  <label>3. </label>
                  <p>Variants detected may vary among laboratories.</p>
                </fn>
                <fn id="melas.TF.1.4">
                  <label>4. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, partial-, whole-, or multigene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="melas.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis and scanning of the entire gene can have similar variant detection frequencies; however, detection rates associated with scanning for pathogenic variants may vary considerably among laboratories depending on the specific protocol used.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="melas.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Typically, blood leukocyte DNA is initially tested for the <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> pathogenic variant, followed by testing for <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.13513G&#x0003e;A</xref>, <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3271T&#x0003e;C</xref>, and <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3252A&#x0003e;G</xref>.</p>
            </list-item>
            <list-item>
              <p>Alternatively, multi-gene panels that include some/all of the genes of interest may be used.</p>
            </list-item>
            <list-item>
              <p>Sequence analysis of the mitochondrial genome is also possible but increases the detection of variants of uncertain clinical significance (see <xref ref-type="sec" rid="melas.Molecular_Genetics">Molecular Genetics</xref>, <bold>Pathogenic allelic variants</bold>).</p>
            </list-item>
          </list>
          <p>As alternatives to blood leukocytes, buccal mucosa, muscle, or urine sediment can be tested for mtDNA pathogenic variants.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="melas.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="melas.Clinical_Description">
          <title>Clinical Description</title>
          <p>MELAS is a multisystem disorder with protean manifestations. In typical cases, onset is in childhood. Early psychomotor development is usually normal, but short stature is common. First onset of symptoms is frequently between ages two and ten years, with some persons having delayed onset between ages ten and 40 years. Onset of symptoms before age two years or after age 40 years is uncommon. The most common initial symptoms are seizures, recurrent headaches, anorexia, and recurrent vomiting. Exercise intolerance or proximal limb weakness can be the initial manifestation, followed by generalized tonic-clonic seizures.</p>
          <table-wrap id="melas.T.melas_age_of_onset" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>MELAS: Age of Onset</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age of Onset (87 individuals)</th>
                  <th id="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Number of Individuals</th>
                  <th id="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Percent (%)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;2 years<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">7<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">2-5 years<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">17<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">6-10 years<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">27<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">31<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">11-20 years<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">17<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">21-40 years<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20<hr/></td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">23<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003e;40 years</td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_melas.T.melas_age_of_onset_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <table-wrap id="melas.T.melas_initial_clinical_manifesta" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p>MELAS: Initial Clinical Manifestation</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Initial Symptom(s) or Sign(s) in 60 Individuals&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Number of Individuals</th>
                  <th id="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Percent (%)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Seizures<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">17<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">28<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Recurrent headaches<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">17<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">28<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Gastrointestinal symptoms (recurrent vomiting, anorexia)<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">25<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Limb weakness<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">11<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">18<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Short stature/stopped growth<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">11<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">18<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Stroke<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">17<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Altered consciousness<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">7<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">12<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Impaired mentation<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">7<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">12<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hearing loss<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">6<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Exercise intolerance<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">6<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Visual symptom<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">5<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Developmental delay<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Fever<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Drop attacks<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1<hr/></td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Impaired gait</td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_melas.T.melas_initial_clinical_manifesta_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="melas.TF.3.1">
                <label>1. </label>
                <p>Affected individuals frequently presented with more than one manifestation.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Seizures are often associated with stroke-like episodes of transient hemiparesis or cortical blindness that may produce altered consciousness and may recur. The cumulative residual effects of the stroke-like episodes gradually impair motor abilities, vision, and mentation, often by adolescence or young adulthood. Sensorineural hearing loss adds to the progressive decline of these individuals.</p>
          <p>Migrainous headaches occur in the majority of affected individuals and are often severe during the acute phase of the stroke.</p>
          <p>Individuals with this condition may also have psychiatric manifestations. A review of the psychiatric manifestations of mitochondrial disorders included 26 individuals with MELAS syndrome with one or more of the following symptoms: major depressive disorder (n=5), cognitive impairment (n=11), psychotic disorder (n=15), anxiety disorder (n=6), frontal lobe syndrome (n=3) or personality change (n=2) [<xref ref-type="bibr" rid="melas.REF.anglin.2012.506">Anglin et al 2012</xref>].</p>
          <p>Less common symptoms include myoclonus, ataxia [<xref ref-type="bibr" rid="melas.REF.petruzzella.2004.64">Petruzzella et al 2004</xref>], episodic coma, optic atrophy, cardiomyopathy [<xref ref-type="bibr" rid="melas.REF.menotti.2004.460">Menotti et al 2004</xref>, <xref ref-type="bibr" rid="melas.REF.wortmann.2007.450">Wortmann et al 2007</xref>], pigmentary retinopathy, ophthalmoplegia, diabetes mellitus, hirsutism, gastrointestinal dysmotility [<xref ref-type="bibr" rid="melas.REF.garciavelasco.2003.381">Garcia-Velasco et al 2003</xref>, <xref ref-type="bibr" rid="melas.REF.chang.2004.374">Chang et al 2004</xref>], and nephropathy.</p>
          <table-wrap id="melas.T.clinical_features_of_110_individ" position="anchor" orientation="portrait">
            <label>Table 4. </label>
            <caption>
              <p>Clinical Features of 110 Individuals with MELAS</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Manifestations</th>
                  <th id="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sign/Symptom</th>
                  <th id="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Present&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Recorded&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Percent (%)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Cardinal</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Exercise intolerance<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">32<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">32<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">100<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Onset &#x0003c;age 40 years<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">79<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">80<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">99<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Stroke<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">106<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">107<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">99<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Seizures<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">97<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">102<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">96<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Ragged red fibers<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">92<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">98<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">95<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Lactic acidosis<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">94<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">101<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">94<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_1" rowspan="12" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Frequent</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Normal early development<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">56<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">62<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">90<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Dementia<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">54<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">60<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">90<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Limb weakness<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">58<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">65<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">89<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hemiparesis<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">57<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">69<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">83<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Short stature<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">58<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">71<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">82<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hemianopsia<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">42<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">53<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">79<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Headache<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">41<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">53<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">77<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Nausea, vomiting<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">49<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">64<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">77<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Onset &#x0003c;age 20 years<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">61<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">80<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">76<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hearing loss<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">46<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">61<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">75<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Learning disability<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">28<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">47<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">60<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">CSF protein &#x0003e;45 mg/dL<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">17<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">36<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">52<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_1" rowspan="13" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Other</bold>
                  </td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Basal ganglia calcification<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">24<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">53<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">45<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Family history<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">37<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">84<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">44<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Myoclonus<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">27<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">72<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">38<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Cerebellar signs<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">23<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">70<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">33<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Episodic coma<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">44<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">20<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Optic atrophy<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">41<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">20<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Congestive heart failure<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">51<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">18<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Pigmentary retinopathy<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">64<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">16<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Wolff-Parkinson-White<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">43<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">14<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Progressive external ophthalmoplegia<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">68<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">13<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Cardiac conduction block<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">47<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">6<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Diabetes mellitus<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">27<hr/></td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">5<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Nephropathy</td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">?</td>
                  <td headers="hd_h_melas.T.clinical_features_of_110_individ_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">?</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="melas.REF.hirano.1994.4">Hirano &#x00026; Pavlakis [1994]</xref></p>
              </fn>
              <fn id="melas.TF.4.1">
                <label>1. </label>
                <p>Present = number of individuals demonstrating a clinical feature</p>
              </fn>
              <fn id="melas.TF.4.2">
                <label>2. </label>
                <p>Recorded = number of individuals evaluated for each clinical feature</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Some individuals have one presentation &#x02013; e.g., progressive external ophthalmoplegia (PEO), diabetes mellitus (DM), cardiomyopathy, or deafness &#x02013; almost exclusively [<xref ref-type="bibr" rid="melas.REF.hirano.1994.4">Hirano &#x00026; Pavlakis 1994</xref>].</p>
          <p>The disease progresses over years with episodic deterioration related to stroke-like events. The course varies from individual to individual. In a cohort of 33 adults with the m.3243A&#x0003e;G MELAS mutation who were followed for three years, deterioration of sensorineural function, cardiac left ventricular hypertrophy, EEG abnormalities, and overall severity were observed [<xref ref-type="bibr" rid="melas.REF.majamaavoltti.2006.1470">Majamaa-Voltti et al 2006</xref>]. In a natural history study of 31 individuals with MELAS and 54 symptomatic and asymptomatic carrier relatives over a follow-up period of up to 10.6 years, neurologic examination, neuropsychological testing, and daily living scores significantly declined in all affected individuals with MELAS, whereas no significant deterioration occurred in carrier relatives. The death rate was more than 17-fold higher in fully symptomatic individuals compared to carrier relatives. The average observed age at death in the affected MELAS group was 34.5&#x000b1;19 years (range 10.2-81.8 years). Of the deaths, 22% occurred in those younger than 18 years. The estimated overall median survival time based on fully symptomatic individuals was 16.9 years from onset of focal neurologic disease [<xref ref-type="bibr" rid="melas.REF.kaufmann.2011.1965">Kaufmann et al 2011</xref>]. A Japanese prospective cohort study of 96 individuals with MELAS confirmed a rapidly progressive course within a five-year interval, with 20.8% of affected individuals dying within a median time of 7.3 years from diagnosis [<xref ref-type="bibr" rid="melas.REF.yatsuga.2012">Yatsuga et al 2012</xref>].</p>
          <p><bold>Neuropathology.</bold> Spongiform encephalopathy, predominantly in the cerebral cortex, has been observed [<xref ref-type="bibr" rid="melas.REF.sparaco.1993.1">Sparaco et al 1993</xref>]. Vascular abnormalities have been found in neuropathologic studies of the brain [<xref ref-type="bibr" rid="melas.REF.betts.2006.359">Betts et al 2006</xref>].</p>
        </sec>
        <sec id="melas.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No clear genotype-phenotype correlations have been identified.</p>
          <p>For all mtDNA pathogenic variants, clinical expression depends on three factors:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Heteroplasmy.</bold> The presence of a mixture of mutant and normal mtDNAs</p>
            </list-item>
            <list-item>
              <p><bold>Tissue distribution</bold> of mutant mtDNAs</p>
            </list-item>
            <list-item>
              <p><bold>Threshold effect.</bold> The vulnerability of each tissue to impaired oxidative metabolism</p>
            </list-item>
          </list>
          <p>While the tissue vulnerability threshold probably does not vary substantially among individuals, mutational load and tissue distribution do vary and may account for the clinical diversity seen in individuals with MELAS. Correlations between the frequency of the more common clinical features and the level of mutant mtDNA in muscle, but not in leukocytes, have been observed [<xref ref-type="bibr" rid="melas.REF.chinnery.1997.1713">Chinnery et al 1997</xref>, <xref ref-type="bibr" rid="melas.REF.jeppesen.2006.1701">Jeppesen et al 2006</xref>]. Diverse clinical presentations (i.e., progressive external ophthalmoplegia, diabetes mellitus, cardiomyopathy, deafness) can be associated with the same <italic toggle="yes">MT-TL1</italic> pathogenic variant, <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref>. This may be the result of the higher abundance of the pathogenic variant in muscle in individuals with progressive external ophthalmoplegia (PEO) than in those with typical MELAS, which may in turn explain why ragged red fibers in individuals with PEO are COX negative rather than COX positive [<xref ref-type="bibr" rid="melas.REF.petruzzella.1994.449">Petruzzella et al 1994</xref>].</p>
          <p>As-yet-undefined nuclear DNA factors may also modify the phenotypic expression of mtDNA pathogenic variants [<xref ref-type="bibr" rid="melas.REF.moraes.1993.43">Moraes et al 1993</xref>].</p>
        </sec>
        <sec id="melas.Penetrance">
          <title>Penetrance</title>
          <p>In mtDNA-related disorders, penetrance typically depends on mutational load and tissue distribution, which show random variation within families (see <xref ref-type="sec" rid="melas.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
        </sec>
        <sec id="melas.Anticipation">
          <title>Anticipation</title>
          <p>No evidence of anticipation has been found. Knowledge of the molecular defect may favor earlier diagnosis in subsequent generations.</p>
        </sec>
        <sec id="melas.Prevalence">
          <title>Prevalence</title>
          <p>An epidemiologic study from northern Finland estimated the prevalence of the <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> pathogenic variant to be greater than or equal to 16.3:100,000 (95% confidence interval 11.3-21.4:100,000) [<xref ref-type="bibr" rid="melas.REF.majamaa.1997.1331">Majamaa et al 1997</xref>]. According to a more recent Finnish study, this estimate may be high [<xref ref-type="bibr" rid="melas.REF.uusimaa.2004.443">Uusimaa et al 2004</xref>]. However, an Australian study found a prevalence of 236:100,000 for <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref>, frequently associated with hearing loss [<xref ref-type="bibr" rid="melas.REF.manwaring.2007.230">Manwaring et al 2007</xref>].</p>
        </sec>
      </sec>
      <sec id="melas.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>The <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> pathogenic variant of <italic toggle="yes">MT-TL1</italic> can also be associated with a variety of mitochondrial disorders including <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">progressive external ophthalmoplegia</related-object> (PEO), maternally inherited diabetes mellitus with or without deafness, cardiomyopathy, or deafness [<xref ref-type="bibr" rid="melas.REF.nesbitt.2013.936">Nesbitt et al 2013</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
      </sec>
      <sec id="melas.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
        <p><bold><italic toggle="yes">POLG</italic>.</bold> One individual with MELAS had compound heterozygous pathogenic variants in the nuclear DNA gene <italic toggle="yes">POLG</italic>, encoding the catalytic subunit of polymerase gamma. See <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic>-Related Disorders</related-object>.</p>
        <p><bold>Acute stroke.</bold> The differential diagnosis includes other causes of stroke in a young person: heart disease, carotid or vertebral diseases, <related-object link-type="booklink" source-id="gene" document-id="sickle" document-type="chapter">sickle cell disease</related-object>, vasculopathies, lipoprotein dyscrasias, venous thrombosis, Moyamoya disease, complicated migraine (see <related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter">Familial Hemiplegic Migraine</related-object>), <related-object link-type="booklink" source-id="gene" document-id="fabry" document-type="chapter">Fabry disease</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="homocystinuria" document-type="chapter">homocystinuria caused by cystathionine beta-synthase deficiency</related-object> [<xref ref-type="bibr" rid="melas.REF.meschia.2004.420">Meschia &#x00026; Worrall 2004</xref>, <xref ref-type="bibr" rid="melas.REF.meschia.2005.122">Meschia et al 2005</xref>]. Besides appropriate specific tests, a maternal history of other problems suggesting mitochondrial dysfunction (short stature, migraine, hearing loss, DM) can help orient the clinician toward the correct diagnosis.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter"><bold>Progressive external ophthalmoplegia</bold></related-object>
<bold>(PEO).</bold> The differential diagnosis includes other forms of ophthalmoparesis:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Myasthenia gravis</bold> (fluctuating weakness, electrophysiologic tests, increased levels of anti-acetylcholine receptor antibodies, lack of family history). It is usually possible to distinguish myasthenia gravis from PEO at the bedside by examining saccadic velocity and performing an edrophonium test.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="opmd" document-type="chapter"><bold>Oculopharyngeal muscular dystrophy</bold></related-object> (late onset, autosomal dominant inheritance, ptosis, mild ophthalmoparesis, dysphagia, limb weakness muscle biopsy showing rimmed vacuoles, molecular genetic testing of <italic toggle="yes">PABPN1</italic>)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter"><bold>Myotonic dystrophy type 1</bold></related-object> (myotonia, facial weakness, distal muscle atrophy, autosomal dominant inheritance, molecular genetic testing of <italic toggle="yes">DMPK</italic>)</p>
          </list-item>
          <list-item>
            <p><bold>PEO with ragged red fibers</bold>. If muscle biopsy shows RRF, the <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">mitochondrial DNA deletion syndromes</related-object> with PEO as well as <related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter">MERRF</related-object> need to be considered. Simplex cases (affected individuals with no known family history of PEO) usually have large-scale single deletions of mtDNA demonstrable by Southern blot analysis of muscle mtDNA, but could have an autosomal dominant or autosomal recessive disorder caused by primary pathogenic variants in nuclear genes [<xref ref-type="bibr" rid="melas.REF.dimauro.2005.276">DiMauro &#x00026; Hirano 2005</xref>]. Maternally inherited PEO in most cases is caused by <italic toggle="yes">MT-TL1</italic> pathogenic variant <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> [<xref ref-type="bibr" rid="melas.REF.moraes.1993.43">Moraes et al 1993</xref>]. However, a small number of additional mtDNA pathogenic variants have been associated with PEO.</p>
          </list-item>
        </list>
        <p><bold>Diabetes mellitus.</bold> Individuals with MELAS who have diabetes mellitus are typically thin, with mid-adult onset. Although individuals initially respond to diet, then to oral hypoglycemic agents, they rapidly develop insulin dependence. MELAS should be considered in individuals with diabetes mellitus who are deaf or have a family history suggesting maternal inheritance.</p>
        <p><bold>Deafness.</bold> See <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Hereditary Hearing Loss and Deafness Overview</related-object> and <related-object link-type="booklink" source-id="gene" document-id="mt-deafness" document-type="chapter">Mitochondrial Nonsyndromic Hearing Loss</related-object>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="mngie" document-type="chapter"><bold>Mitochondrial neurogastrointestinal encephalopathy</bold></related-object>
<bold>(MNGIE) disease.</bold> When gastrointestinal dysmotility, cachexia, and neuropathy are prominent, MNGIE needs to be considered [<xref ref-type="bibr" rid="melas.REF.hirano.2004.8">Hirano et al 2004</xref>].</p>
      </sec>
      <sec id="melas.Management">
        <title>Management</title>
        <sec id="melas.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with MELAS, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of height and weight to assess growth</p>
            </list-item>
            <list-item>
              <p>Audiologic evaluation</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>Assessment of cognitive abilities</p>
            </list-item>
            <list-item>
              <p>Physical therapy assessment</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation, MRI, MRS [<xref ref-type="bibr" rid="melas.REF.kaufmann.2004.1297">Kaufmann et al 2004</xref>], and, if seizures are suspected, EEG</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation</p>
            </list-item>
            <list-item>
              <p>Screening for diabetes mellitus by fasting serum glucose concentration and glucose tolerance test</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="melas.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Sensorineural hearing loss has been successfully treated with cochlear implantation [<xref ref-type="bibr" rid="melas.REF.sue.1998.350">Sue et al 1998</xref>, <xref ref-type="bibr" rid="melas.REF.scarpelli.2012">Scarpelli et al 2012</xref>].</p>
          <p>Ptosis can benefit from eyelid "crutches," blepharoplasty, or frontalis muscle-eyelid sling placement.</p>
          <p>No therapy is available for PEO or retinopathy.</p>
          <p>Aerobic exercise is helpful in MELAS and other mitochondrial diseases [<xref ref-type="bibr" rid="melas.REF.taivassalo.2004.221">Taivassalo &#x00026; Haller 2004</xref>]. Physical therapy should be implemented in individuals after strokes.</p>
          <p>Seizures respond to traditional anticonvulsant therapy.</p>
          <p>Standard analgesics can be used for migraine headaches.</p>
          <p>Cardiac manifestations can benefit from standard pharmacologic therapy.</p>
          <p>Diabetes mellitus can be managed by dietary modification only, especially in thin individuals, or with oral hypoglycemic agents, but often requires insulin therapy.</p>
          <p>L-arginine showed promise in treating stroke-like episodes in MELAS [<xref ref-type="bibr" rid="melas.REF.koga.2010.104">Koga et al 2010</xref>].</p>
        </sec>
        <sec id="melas.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>No specific treatment for MELAS exists.</p>
          <p>The administration of coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) (50-100 mg 3x/day) and L-carnitine (1000 mg 3x/day) has been of some benefit to some individuals. In a small randomized double-blind placebo-controlled study, CoQ<sub>10</sub> combined with creatine and lipoic acid produced modest benefits including slowing progression of ankle weakness and lower resting plasma lactate concentration [<xref ref-type="bibr" rid="melas.REF.rodriguez.2007.235">Rodriguez et al 2007</xref>].</p>
          <p>Idebenone, an analog of CoQ<sub>10</sub> that crosses the blood-brain barrier more efficiently, has also been reported as beneficial in anecdotal reports [<xref ref-type="bibr" rid="melas.REF.napolitano.2000.s981">Napolitano et al 2000</xref>]. A clinical trial of idebenone for MELAS is in progress [Author, personal observation].</p>
        </sec>
        <sec id="melas.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Because febrile illnesses may trigger acute exacerbations, individuals with MELAS should receive standard childhood vaccinations, flu vaccine, and pneumococcal vaccine.</p>
        </sec>
        <sec id="melas.Surveillance">
          <title>Surveillance</title>
          <p>Affected individuals and their at-risk relatives should be followed at regular intervals to monitor progression and the appearance of new symptoms. Annual ophthalmologic, cardiologic (electrocardiogram and echocardiogram), and endocrinologic evaluations (fasting blood sugar and TSH) are recommended.</p>
        </sec>
        <sec id="melas.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with MELAS should avoid mitochondrial toxins such as: aminoglycoside antibiotics, linezolid, cigarettes, and alcohol. Valproic acid should be avoided in the treatment of seizures [<xref ref-type="bibr" rid="melas.REF.lin.2007.105">Lin &#x00026; Thajeb 2007</xref>].</p>
          <p>Dichloroacetate (DCA) reduces blood lactate by activating the pyruvate dehydrogenase complex. Anecdotal reports of effectiveness have not been substantiated by a double-blind, placebo-controlled trial, which in fact documented a toxic effect of DCA on peripheral nerves and concluded that individuals with MELAS (who are already at increased risk for peripheral neuropathies) should avoid DCA [<xref ref-type="bibr" rid="melas.REF.kaufmann.2006a.324">Kaufmann et al 2006a</xref>].</p>
        </sec>
        <sec id="melas.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Molecular genetic testing of at-risk maternal relatives may reveal individuals who have high mutational loads and are thus at risk of developing symptoms. However, no proven disease-modifying intervention exists at present.</p>
          <p>See <xref ref-type="sec" rid="melas.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="melas.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Infertility may preclude pregnancy in some affected individuals. Women with MELAS should receive genetic counseling prior to pregnancy. During pregnancy, affected or at-risk women should be monitored for diabetes mellitus and respiratory insufficiency, which may require therapeutic interventions [<xref ref-type="bibr" rid="melas.REF.d_azlobato.2005.654">D&#x000ed;az-Lobato et al 2005</xref>].</p>
        </sec>
        <sec id="melas.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Oral administration of L-arginine seems to attenuate the severity of strokes when administered in the acute phase [<xref ref-type="bibr" rid="melas.REF.koga.2005.710">Koga et al 2005</xref>] and to reduce the frequency of strokes when given interictally [<xref ref-type="bibr" rid="melas.REF.koga.2005.710">Koga et al 2005</xref>, <xref ref-type="bibr" rid="melas.REF.koga.2010.104">Koga et al 2010</xref>]; double-blind studies are needed to confirm these data.</p>
          <p>Beneficial effects of oral succinate were reported in one individual [<xref ref-type="bibr" rid="melas.REF.oguro.2004.427">Oguro et al 2004</xref>].</p>
          <p>The role of heart transplantation for progressive cardiomyopathy has been reviewed [<xref ref-type="bibr" rid="melas.REF.bhati.2005.2286">Bhati et al 2005</xref>].</p>
          <p>The transfer of nuclear DNA from fertilized oocytes or zygotes harboring a mtDNA pathogenic variant to a recipient enucleated recipient cells could theoretically prevent transmission of mtDNA diseases and proof of this concept has been demonstrated in pronuclear transfers from abnormally fertilized zygotes that were allowed to under several replications in vitro [<xref ref-type="bibr" rid="melas.REF.craven.2010.82">Craven et al 2010</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="melas.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="melas.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>MELAS is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance.</p>
        </sec>
        <sec id="melas.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a proband does not have the mtDNA pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The mother of a proband usually has the mtDNA pathogenic variant and may or may not have symptoms. In some mothers, the pathogenic variant may be undetectable in mtDNA from leukocytes and may be detected in other tissues, such as cultured skin fibroblasts, hair follicles, urinary sediment, or (most reliably) skeletal muscle.</p>
            </list-item>
            <list-item>
              <p>Alternatively, the proband may have a <italic toggle="yes">de novo</italic> somatic mitochondrial pathogenic variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs depends on the genetic status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother has the mtDNA pathogenic variant, all the sibs of a proband will inherit the mtDNA pathogenic variant and may or may not have symptoms. One group has reported that women with higher levels of mutant mtDNA in their blood have a greater likelihood of having affected offspring [<xref ref-type="bibr" rid="melas.REF.chinnery.1998.1889">Chinnery et al 1998</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>All offspring of females with a mtDNA pathogenic variant will inherit the variant.</p>
            </list-item>
            <list-item>
              <p>Offspring of males with a mtDNA pathogenic variant are not at risk of inheriting the variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's mother.</p>
            </list-item>
            <list-item>
              <p>If she has a mtDNA pathogenic variant, her sibs and mother are also at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="melas.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Phenotypic variability.</bold> Family members with the <italic toggle="yes">MT-TL1</italic> pathogenic variant <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> are more likely to have non-MELAS manifestations (i.e., diabetes mellitus, hearing loss).</p>
          <p>The phenotype of an individual with a mtDNA pathogenic variant results from a combination of factors including the severity of the pathogenic variant, the percentage of mutated mitochondria (mutational load), and the organs and tissues in which they are found (tissue distribution). Different family members often inherit different percentages of mutant mtDNA and therefore can have a wide range of clinical symptoms.</p>
          <p><bold>Interpretation of test results of asymptomatic at-risk family members</bold> is extremely difficult. Prediction of phenotype based on test results is not possible.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling&#x000a0;(including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="melas.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Although prenatal testing for mtDNA pathogenic variants causing MELAS is of uncertain utility, it may be available from a clinical laboratory that offers either testing of the relevant gene or custom prenatal testing. The specific mtDNA pathogenic variant in the mother must be identified before prenatal testing can be performed.</p>
          <p>Changes in mutational load during pregnancy were evaluated in a small study of nine pregnancies in five women from families with the <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">m.3243A&#x0003e;G</xref> mtDNA pathogenic variant. Mutational loads in chorionic villi (which were analyzed once) and in amniocytes (analyzed once or twice during pregnancy) were found to be stable [<xref ref-type="bibr" rid="melas.REF.bouchet.2006.788">Bouchet et al 2006</xref>]. Eleven pregnancies with fetal mutation levels 35% or lower (assessed with prenatal diagnosis or PGD) resulted in healthy children who have been followed for one month to five years; one pregnancy, with 63% mutation level in the fetus, was terminated [<xref ref-type="bibr" rid="melas.REF.monnot.2011.116">Monnot et al 2011</xref>, <xref ref-type="bibr" rid="melas.REF.treff.2012.1236">Treff et al 2012</xref>]. Additional studies are necessary to establish the value of prenatal testing.</p>
          <p>Interpretation of prenatal diagnostic results is complex for the following reasons:</p>
          <list list-type="bullet">
            <list-item>
              <p>The mutational load in the mother's tissues and in fetal tissues sampled (i.e., amniocytes and chorionic villi) may not correspond to that of other fetal tissues.</p>
            </list-item>
            <list-item>
              <p>The mutational load in tissues sampled prenatally may shift in utero or after birth as a result of random mitotic segregation.</p>
            </list-item>
          </list>
          <p>Prediction of phenotype, age of onset, severity, or rate of progression is not possible.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="melas.Resources">
        <title>Resources</title>
      </sec>
      <sec id="melas.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="melas.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The pathogenic mechanism is not completely clear, but interesting insights were obtained from studies of cybrid cell lines. Cybrids are mtDNA-less human immortal cell lines (rho<sup>0</sup> cells) repopulated with mitochondria from individuals with MELAS harboring the m.3243A&#x0003e;G or other pathogenic variants [<xref ref-type="bibr" rid="melas.REF.king.1989.500">King &#x00026; Attardi 1989</xref>]. The cybrid cell-line studies showed that high proportions of the <italic toggle="yes">MT-TL1</italic> m.3243A&#x0003e;G pathogenic variant correlated with decreased mitochondrial protein synthesis, decreased oxygen consumption, and increased amounts of an unprocessed RNA fragment containing the mutated gene and designated RNA-19 [<xref ref-type="bibr" rid="melas.REF.king.1992.480">King et al 1992</xref>]. High levels of RNA-19 were documented in tissues from individuals with MELAS [<xref ref-type="bibr" rid="melas.REF.kaufmann.1996.172">Kaufmann et al 1996</xref>]. Other studies have demonstrated low levels of the mutant tRNA, decreased aminoacylation, and hypomodification of the D-stem &#x02013; alterations that may contribute to the observed decreased protein synthesis [<xref ref-type="bibr" rid="melas.REF.helm.1999.756">Helm et al 1999</xref>, <xref ref-type="bibr" rid="melas.REF.b_rner.2000.467">B&#x000f6;rner et al 2000</xref>, <xref ref-type="bibr" rid="melas.REF.chomyn.2000.19198">Chomyn et al 2000</xref>]. An alternative theory, also based on cybrid work, attributes the pathogenesis of the variant to a misreading of leucine codons as phenylalanine codons [<xref ref-type="bibr" rid="melas.REF.yasukawa.2000.4251">Yasukawa et al 2000</xref>] because of lack of methyltaurine modification of the anticodon wobble base [<xref ref-type="bibr" rid="melas.REF.kirino.2004.15070">Kirino et al 2004</xref>].</p>
          <p><bold>Benign allelic variants.</bold> Benign polymorphisms are especially frequent in mtDNA and are listed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/">www.mitomap.org</ext-link>. The mtDNA encodes 22 tRNAs that are essential for mitochondrial protein synthesis, specifically for the incorporation of amino acids into nascent proteins. Nine of the genes discussed in this <italic toggle="yes">GeneReview</italic> are tRNA genes: <italic toggle="yes">MT-TL1</italic>, <italic toggle="yes">MT-TC</italic>, <italic toggle="yes">MT-TF</italic>, <italic toggle="yes">MT-TV</italic>, <italic toggle="yes">MT-TQ</italic>, <italic toggle="yes">MT-TW</italic>, <italic toggle="yes">MT-TS1</italic>, <italic toggle="yes">MT-TS2</italic>, and <italic toggle="yes">MT-TK</italic>. Seven protein-encoding genes are also discussed. See <related-object source-id="gene" document-id="melas" object-id="melas.molgen.TB">Table B</related-object>.</p>
          <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">Table 5</xref>.</p>
          <p>Twenty-nine single-nucleotide variants and one 4-bp deletion in <italic toggle="yes">MT-CYB</italic> have been associated with the MELAS syndrome (<xref ref-type="table" rid="melas.T.pathogenic_variants_in_mitochond">Table 5</xref>).</p>
          <table-wrap id="melas.T.pathogenic_variants_in_mitochond" position="anchor" orientation="portrait">
            <label>Table 5. </label>
            <caption>
              <p>Pathogenic Variants in Mitochondrial DNA Associated with MELAS</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% of Affected Individuals</th>
                  <th id="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mitochondrial DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">References</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">~80%<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.3243A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-TL1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" rowspan="17" valign="middle" align="left" colspan="1">No protein translated<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" rowspan="17" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.goto.1990.651">Goto et al [1990]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">~&#x0003c;10%<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.3271T&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.goto.1991.238">Goto et al [1991]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;5%<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.3252A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.morten.1993.2081">Morten et al [1993]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="20" valign="middle" align="left" scope="row" colspan="1">Rare<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.3291T&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.goto.1994.1624">Goto et al [1994]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3256C&#x0003e;T<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.sato.1994.1055">Sato et al [1994]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3260A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.nishino.1996.1603">Nishino et al [1996]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.583G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TF</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.hanna.1998.512">Hanna et al [1998]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.1642G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-TV</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.taylor.1996.459">Taylor et al [1996]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.1644G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.tanji.2008.23">Tanji et al [2008]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.4332G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TQ</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.bataillard.2001.405">Bataillard et al [2001]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.5521G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TW</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.herreromart_n.2010.471">Herrero-Mart&#x000ed;n et al [2010]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.5814A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TC</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.manfredi.1996.158">Manfredi et al [1996]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.7512T&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TS1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.lindberg.2008.128">Lindberg et al [2008]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.12146A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-TL2</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.calvaruso.2011.778">Calvaruso et al [2011]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.12299A&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.abuamero.2009.77">Abu-Amero et al [2009]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.8316T&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TK</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.campos.2000.493">Campos et al [2000]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.8296A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TK</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.sakuta.2002.397">Sakuta et al [2002]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3481G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-ND1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Gln59Lys<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/254028369">ACT53096.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.malfatti.2007.1894">Malfatti et al [2007]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3697G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-ND1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Gly131Ser<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/254028369">ACT53096.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.kirby.2004.784">Kirby et al [2004]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3946G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-ND1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Gln214Lys<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/254028369">ACT53096.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.kirby.2004.784">Kirby et al [2004]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.3949T&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-ND1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr215His<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/254028369">ACT53096.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.kirby.2004.784">Kirby et al [2004]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.7023G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-CO2</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Val374Met<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/254028369">ACT53096.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.tam.2008.328">Tam et al [2008]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.9957T&#x0003e;C<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-CO3</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Phe251Leu<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_536849.1?report=genpept">NP_536849.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.manfredi.1995.391">Manfredi et al [1995]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;10%<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.13513G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">MT-ND5<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Asp393Asn<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" rowspan="6" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_536853.1?report=genpept">NP_536853.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.santorelli.1997.326">Santorelli et al [1997]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_1" rowspan="8" valign="middle" align="left" scope="row" colspan="1">Rare</td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">m.12770A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">p.Glu145Gly<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.liolitsa.2003.128">Liolitsa et al [2003]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.13042G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">p.Ala236Thr<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.naini.2005.473">Naini et al [2005]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.13084A&#x0003e;T<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">p.Ser250Cys<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.crimi.2003.1857">Crimi et al [2003]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.13514A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">p.Asp393Gly<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.corona.2001.106">Corona et al [2001]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.13528A&#x0003e;G<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">p.Thr398Ala<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.mckenzie.2007.36845">McKenzie et al [2007]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.14453G&#x0003e;A<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-ND6</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Ala74Val<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_536854.1?report=genpept">NP_536854.1</ext-link>
                    <hr/>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.ravn.2001.805">Ravn et al [2001]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.14787delTTAA<break/>(4-bp del)<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-CYB</italic>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">p.Ile14Thrfs<hr/></td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_5" rowspan="2" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NC_012920.1?report=graph&#x00026;log$=seqview">NC_012920.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_536855.1?report=genpept">NP_536855.1</ext-link>
                  </td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="melas.REF.de_coo.1999.130">De Coo et al [1999]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">m.14864T&#x0003e;C</td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">p.Cys40Arg</td>
                  <td headers="hd_h_melas.T.pathogenic_variants_in_mitochond_1_1_1_6" valign="middle" colspan="1" align="left" rowspan="1">
                    <xref ref-type="bibr" rid="melas.REF.emmanuele.2013.236">Emmanuele et al [2013]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature (Note: The mitochondrial genetic code varies from the genomic genetic code given in the Quick Reference. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org">www.mitomap.org</ext-link> for genetic code and other features of the mitochondrial genome). Variants named according to current nomenclature guidelines (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org">varnomen.hgvs.org</ext-link>)</p>
              </fn>
              <fn id="melas.TF.5.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="melas.TF.5.2">
                <label>2. </label>
                <p>Numbering based on mitochondrial DNA reference sequence: AC_000021.2 and individual protein reference sequences</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>For more information, see <related-object source-id="gene" document-id="melas" object-id="melas.molgen.TA">Table A</related-object> and <related-object source-id="gene" document-id="melas" object-id="melas.molgen.TB">Table B</related-object>.</p>
          <p>Sequence analysis of the mitochondrial genome can be performed to screen for pathogenic variants. As with other sequence-based testing, this approach detects known mtDNA pathogenic variants, however, it has the disadvantage of also detecting variants of uncertain clinical significance [<xref ref-type="bibr" rid="melas.REF.bannwarth.2013.704">Bannwarth et al 2013</xref>, <xref ref-type="bibr" rid="melas.REF.tang.2013.882">Tang et al 2013</xref>]. For example, a study of whole mtDNA sequencing of 743 individuals suspected of having mitochondrial diseases found 65 (7.4%) individuals had known pathogenic variants, while 167 (22.4%) carried &#x0201c;putative&#x0201d; pathogenic variants [<xref ref-type="bibr" rid="melas.REF.bannwarth.2013.704">Bannwarth et al 2013</xref>]. Interpretation of such &#x0201c;putative pathogenic variants&#x0201d; may be complex, requiring additional testing in clinical and/or research laboratories. Interpretation requires application of existing pathogenicity criteria including: assessments of evolutionary conservation, in silico predictions of pathogenicity of the amino acid or nucleotide alterations, mtDNA heteroplasmy vs. homoplasmy, segregation of the variant in the family, correlations with biochemical defects, single-fiber PCR (to measure heteroplasmy in single COX-negative muscle fibers or ragged-red fibers vs. normal fibers), and cybrid cell analyses [<xref ref-type="bibr" rid="melas.REF.dimauro.2001.18">DiMauro &#x00026; Schon 2001</xref>, <xref ref-type="bibr" rid="melas.REF.yarham.2011.1319">Yarham et al 2011</xref>]. Accordingly, in persons with mtDNA sequence variants of uncertain significance, muscle biopsies are particularly useful in assessing pathogenicity of the variants, particularly when heteroplasmic, and therefore amenable to single-fiber analyses.</p>
          <p><bold>Normal gene product.</bold> MT-CO2, cytochrome <italic toggle="yes">c</italic> oxidase subunit II (227 amino acids) and MT-CO3, cytochrome <italic toggle="yes">c</italic> oxidase subunit III (261 amino acids) are catalytic subunits of mitochondrial complex IV, which is the terminal electron acceptor of the respiratory chain.</p>
          <p>MT-CYB, cytochrome <italic toggle="yes">b</italic> (112 amino acids) is an essential subunit of mitochondrial respiratory chain complex III.</p>
          <p>MT-ND1, NADH dehydrogenase subunit 1 (318 amino acids); MT-ND5, NADH dehydrogenase subunit 5 (603 amino acids); and MT-ND6, NADH dehydrogenase subunit 6 (174 amino acids) are critical components of mitochondrial respiratory chain complex I.</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants in the structural subunits of the mitochondrial respiratory chain complexes impair synthesis of ATP via oxidative phosphorylation and elevate lactic acid levels in blood and cerebrospinal fluid.</p>
        </sec>
      </sec>
      <sec id="melas.References">
        <title>References</title>
        <sec id="melas.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="melas.Literature_Cited.reflist0">
            <ref id="melas.REF.abuamero.2009.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dhalaan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>A patient with typical clinical features of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) but without an obvious genetic cause: a case report.</article-title>
                <source>J Med Case Rep.</source>
                <year>2009</year>
                <volume>3</volume>
                <fpage>77</fpage>
                <pub-id pub-id-type="pmid">19946553</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.anglin.2012.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anglin</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garside</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazurek</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosebush</surname>
                    <given-names>PI</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>The psychiatric manifestations of mitochondrial disorders: a case and review of the literature.</article-title>
                <source>J Clin Psychiatry</source>
                <volume>73</volume>
                <fpage>506</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">22579150</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.bannwarth.2013.704">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bannwarth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebre</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussenot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoarau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maoulida</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charrier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gai</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fragaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mousson de Camaret</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhaenens</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul Bonnefont</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoutil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilleron</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desquiret-Dumas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceresuela</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espil-Taris</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaignard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Quan Sang</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falk</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florentz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand-Zaleski</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquis-Flucklinger</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Prevalence of rare mitochondrial DNA mutations in mitochondrial disorders.</article-title>
                <source>J Med Genet</source>
                <volume>50</volume>
                <fpage>704</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">23847141</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.bataillard.2001.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bataillard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chatzoglou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbach</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournade</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maisonobe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombes</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>405</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11171912</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.betts.2006.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Betts</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaros</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdel-All</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <volume>32</volume>
                <fpage>359</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">16866982</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.bhati.2005.2286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bhati</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheridan</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mill</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selzman</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome.</article-title>
                <source>J Heart Lung Transplant.</source>
                <volume>24</volume>
                <fpage>2286</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16364883</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.b_rner.2000.467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000f6;rner</surname>
                    <given-names>GV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerbitz</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pongratz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holme</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e4;&#x000e4;bo</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2000</year>
                <month>Mar</month>
                <day>1</day>
                <volume>9</volume>
                <issue>4</issue>
                <fpage>467</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">10699170</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.bouchet.2006.788">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouchet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steffann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corcos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monnot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;tig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Royer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gigarel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benachi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumez</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>788</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16690729</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.calvaruso.2011.778">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Calvaruso</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodenburg</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Brand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijtmans</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>New mitochondrial tRNA HIS mutation in a family with lactic acidosis and stroke-like episodes (MELAS).</article-title>
                <source>Mitochondrion.</source>
                <year>2011</year>
                <volume>11</volume>
                <fpage>778</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">21704194</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.campos.2000.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenzo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torregrosa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Hoyo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A mitochondrial tRNA(Lys) gene mutation (T8316C) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>10</volume>
                <fpage>493</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10996780</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.chang.2004.374">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Paralytic ileus in MELAS with phenotypic features of MNGIE.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>31</volume>
                <fpage>374</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15519124</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.chinnery.1997.1713">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes.</article-title>
                <source>Brain</source>
                <volume>120</volume>
                <fpage>1713</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">9365365</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.chinnery.1998.1889">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring.</article-title>
                <source>Brain</source>
                <volume>121</volume>
                <fpage>1889</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">9798744</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.chomyn.2000.19198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chomyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enriquez</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micol</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Silva</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attardi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes.</article-title>
                <source>J Biol Chem</source>
                <volume>275</volume>
                <fpage>19198</fpage>
                <lpage>209</lpage>
                <pub-id pub-id-type="pmid">10858457</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.corona.2001.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corona</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Incerti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>106</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">11198278</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.craven.2010.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Craven</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuppen</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greggains</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbottle</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cree</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murdoch</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.</article-title>
                <source>Nature.</source>
                <volume>465</volume>
                <fpage>82</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20393463</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.crimi.2003.1857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crimi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galbiati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perini</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biunno</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1857</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">12796552</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.de_coo.1999.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renier</surname>
                    <given-names>WO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruitenbeek</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ter Laak</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schagger</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Oost</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>45</volume>
                <fpage>130</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9894888</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.d_azlobato.2005.654">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x000ed;az-Lobato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez Mendieta</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreno Garc&#x000ed;a</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayoralas-Alises</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arpa Gutierrez</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <article-title>Two full-term pregnancies in a patient with mitochondrial myopathy and chronic ventilatory insufficiency.</article-title>
                <source>Respiration.</source>
                <year>2005</year>
                <month>Nov-Dec</month>
                <volume>72</volume>
                <issue>6</issue>
                <fpage>654</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16355006</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.dimauro.1997">
              <mixed-citation publication-type="book">DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds. <italic toggle="yes">The Molecular and Genetic Basis of Neurological Disease.</italic> Boston, MA: Butterworth-Heinemann; 1997:201-35.</mixed-citation>
            </ref>
            <ref id="melas.REF.dimauro.2005.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dimauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidzon</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA and disease.</article-title>
                <source>Ann Med.</source>
                <year>2005</year>
                <volume>37</volume>
                <issue>3</issue>
                <fpage>222</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16019721</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.dimauro.2005.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mitochondrial encephalomyopathies: an update.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>15</volume>
                <fpage>276</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">15792866</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.dimauro.2001.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mitochondrial DNA mutations in human disease.</article-title>
                <source>Am J Med Genet</source>
                <volume>106</volume>
                <fpage>18</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">11579421</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.emmanuele.2013.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emmanuele</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotiriou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rios</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganesh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichord</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foley</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A novel mutation in the mitochondrial DNA cytochrome b gene (MTCYB) in a patient with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes syndrome.</article-title>
                <source>J Child Neurol</source>
                <volume>28</volume>
                <fpage>236</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">22638077</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.filosto.2007.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomelleri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarpelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vattemi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzuto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padovani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonati</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Neuropathology of mitochondrial diseases.</article-title>
                <source>Biosci Rep.</source>
                <volume>27</volume>
                <fpage>23</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">17541738</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.garciavelasco.2003.381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia-Velasco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez-Escalonilla</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerra-Vales</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Intestinal pseudo-obstruction and urinary retention: cardinal features of a mitochondrial DNA-related disease.</article-title>
                <source>J Intern Med</source>
                <volume>253</volume>
                <fpage>381</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12603507</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.goto.1990.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horai</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.</article-title>
                <source>Nature</source>
                <volume>348</volume>
                <fpage>651</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">2102678</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.goto.1991.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horai</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1097</volume>
                <fpage>238</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">1932147</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.goto.1994.1624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsugane</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horai</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>202</volume>
                <fpage>1624</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">7520241</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.hanna.1998.512">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan-Hughes</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>65</volume>
                <fpage>512</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9771776</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.hasegawa.1991.601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuoka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.</article-title>
                <source>Ann Neurol</source>
                <volume>29</volume>
                <fpage>601</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">1892363</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.helm.1999.756">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Helm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florentz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chomyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attardi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Search for differences in post-transcriptional modification patterns of mitochondrial DNA-encoded wild-type and mutant human tRNALys and tRNALeu(UUR).</article-title>
                <source>Nucleic Acids Res</source>
                <volume>27</volume>
                <fpage>756</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">9889270</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.herreromart_n.2010.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herrero-Mart&#x000ed;n</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tu&#x000f1;&#x000f3;n</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Pesini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montoya</surname>
                    <given-names>J. A</given-names>
                  </name>
                </person-group>
                <article-title>MELAS/MERRF phenotype associated with the mitochondrial DNA 5521G&#x0003e;A mutation.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2010</year>
                <month>Apr</month>
                <volume>81</volume>
                <issue>4</issue>
                <fpage>471</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">20360171</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.hirano.2004.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishigaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A disease of two genomes.</article-title>
                <source>Neurologist</source>
                <volume>10</volume>
                <fpage>8</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">14720311</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.hirano.1994.4">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlakis</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts.</article-title>
                <source>J Child Neurol</source>
                <volume>9</volume>
                <fpage>4</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">8151079</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.hirano.1992.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenigsberger</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defendini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlakis</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeVivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Melas: an original case and clinical criteria for diagnosis.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>2</volume>
                <fpage>125</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">1422200</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.iizuka.2003.1238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iizuka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Slowly progressive spread of the stroke-like lesions in MELAS.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>1238</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">14610127</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.jeppesen.2006.1701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jeppesen</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frederiksen</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Muscle phenotype and mutation load in 51 persons with the 3243A&#x0003e;G mitochondrial DNA mutation.</article-title>
                <source>Arch Neurol.</source>
                <volume>63</volume>
                <fpage>1701</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17172609</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.k_rpp_.2003.216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000e4;rpp&#x000e4;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syrj&#x000e4;l&#x000e4;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolonen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Peripheral neuropathy in patients with the 3243A&#x0003e;G mutation in mitochondrial DNA.</article-title>
                <source>J Neurol.</source>
                <year>2003</year>
                <month>Feb</month>
                <volume>250</volume>
                <issue>2</issue>
                <fpage>216</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12574954</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kaufmann.2006a.324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millar</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooch</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacpoole</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2006a</year>
                <article-title>Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.</article-title>
                <source>Neurology.</source>
                <volume>66</volume>
                <fpage>324</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16476929</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kaufmann.2011.1965">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulikova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oskoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sproule</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battista</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenigsberger</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Natural history of MELAS associated with mitochondrial DNA m.3243A&#x0003e;G genotype.</article-title>
                <source>Neurology</source>
                <volume>77</volume>
                <fpage>1965</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">22094475</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kaufmann.1996.172">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Mitochondrial DNA and RNA processing in MELAS.</article-title>
                <source>Ann Neurol</source>
                <volume>40</volume>
                <fpage>172</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">8773598</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kaufmann.2006b.746">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anziska</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooch</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2006b</year>
                <article-title>Nerve conduction abnormalities in patients with MELAS and the A3243G mutation.</article-title>
                <source>Arch Neurol</source>
                <volume>63</volume>
                <fpage>746</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16682545</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kaufmann.2004.1297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cerebral lactic acidosis correlates with neurological impairment in MELAS.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1297</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">15111665</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.king.1989.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attardi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.</article-title>
                <source>Science</source>
                <volume>246</volume>
                <fpage>500</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">2814477</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.king.1992.480">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.</article-title>
                <source>Mol Cell Biol</source>
                <volume>12</volume>
                <fpage>480</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">1732728</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kirby.2004.784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtake</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunning</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ketteridge</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorburn</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations of the mitochondrial ND1 gene as a cause of MELAS.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>784</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15466014</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kirino.2004.15070">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirino</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasukawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akira</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishihara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>101</volume>
                <fpage>15070</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15477592</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.koga.2005.710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishioka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yatsuga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Povalko</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuishi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>L-arginine improves the symptoms of strokelike episodes in MELAS.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>710</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15728297</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.koga.2010.104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Povalko</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishioka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakimoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuishi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1201</volume>
                <fpage>104</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20649546</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.kolb.2003.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kolb</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costello</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messe</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellenbogen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasner</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galetta</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping.</article-title>
                <source>J Neurol Sci</source>
                <volume>216</volume>
                <fpage>11</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">14607297</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.lin.2007.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thajeb</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.</article-title>
                <source>Metab Brain Dis</source>
                <volume>22</volume>
                <fpage>105</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17226098</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.lindberg.2008.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslemi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>MELAS syndrome in a patient with a point mutation in MTTS1.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>117</volume>
                <fpage>128</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">17894844</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.liolitsa.2003.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liolitsa</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?</article-title>
                <source>Ann Neurol</source>
                <volume>53</volume>
                <fpage>128</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12509858</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.majamaa.1997.1331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turkka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karppa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winqvist</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassinen</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1331</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9371917</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.majamaavoltti.2006.1470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Majamaa-Voltti</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winqvist</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolonen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyhtinen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uimonen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e4;rpp&#x000e4;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peuhkurinen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A 3-year clinical follow-up of adult patients with 3243A&#x0003e;G in mitochondrial DNA.</article-title>
                <source>Neurology.</source>
                <volume>66</volume>
                <fpage>1470</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16717204</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.malfatti.2007.1894">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malfatti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Invernizzi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Souza</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antozzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Confalonieri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanseverino</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giugliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>1894</fpage>
                <lpage>904</lpage>
                <pub-id pub-id-type="pmid">17535832</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.manfredi.1996.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manfredi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraes</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy.</article-title>
                <source>Hum Mutat</source>
                <volume>7</volume>
                <fpage>158</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">8829635</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.manfredi.1995.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manfredi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraes</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sladky</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>5</volume>
                <fpage>391</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7496173</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.manwaring.2007.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manwaring</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochtchina</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Population prevalence of the MELAS A3243G mutation.</article-title>
                <source>Mitochondrion</source>
                <volume>7</volume>
                <fpage>230</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">17300999</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.mcdonnell.2004.778">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McDonnell</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Noninvasive diagnosis of the 3243A &#x0003e; G mitochondrial DNA mutation using urinary epithelial cells.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>12</volume>
                <fpage>778</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">15199381</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.mckenzie.2007.36845">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McKenzie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liolitsa</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akinshina</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campanella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisodiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hargreaves</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nirmalananthan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abou-Sleiman</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duchen</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption.</article-title>
                <source>J Biol Chem.</source>
                <volume>282</volume>
                <fpage>36845</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">17940288</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.menotti.2004.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Menotti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brega</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diegoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grasso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modena</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbustini</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS.</article-title>
                <source>Ital Heart J</source>
                <volume>5</volume>
                <fpage>460</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15320572</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.meschia.2005.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meschia</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brott</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RD</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetics of cerebrovascular disorders.</article-title>
                <source>Mayo Clin Proc</source>
                <volume>80</volume>
                <fpage>122</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15667040</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.meschia.2004.420">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meschia</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worrall</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>New advances in identifying genetic anomalies in stroke-prone probands.</article-title>
                <source>Curr Neurol Neurosci Rep</source>
                <volume>4</volume>
                <fpage>420</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15324609</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.monnot.2011.116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monnot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gigarel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hesters</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frydman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frydman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerbrat</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funalot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinovic</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benachi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steffann</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Segregation of mtDNA throughout human embryofetal development: m.3243A&#x0003e;G as a model system.</article-title>
                <source>Hum Mutat</source>
                <volume>32</volume>
                <fpage>116</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">21120938</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.moraes.1993.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moraes</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciacci</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>3</volume>
                <fpage>43</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">8392410</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.morten.1993.2081">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morten</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lake</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pike</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>A new point mutation associated with mitochondrial encephalomyopathy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>2</volume>
                <fpage>2081</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8111377</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.naini.2005.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>473</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15767514</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.napolitano.2000.s981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vista</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombardi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraldi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Long-term treatment with idebenone and riboflavin in a patient with MELAS.</article-title>
                <source>Neurol Sci</source>
                <volume>21</volume>
                <fpage>S981</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11382201</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.nesbitt.2013.936">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nesbitt</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitceathly</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mudanohwo</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>The UK MRC mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A&#x0003e;G mutation--Implications for diagnosis and management.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>84</volume>
                <fpage>936</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23355809</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.nishino.1996.1603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kodama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horai</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS).</article-title>
                <source>Muscle Nerve</source>
                <volume>19</volume>
                <fpage>1603</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8941275</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.oguro.2004.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oguro</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iijima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bokura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Successful treatment with succinate in a patient with MELAS.</article-title>
                <source>Intern Med</source>
                <volume>43</volume>
                <fpage>427</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15206559</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.petruzzella.1994.449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Petruzzella</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraes</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243.</article-title>
                <source>Hum Mol Genet</source>
                <volume>3</volume>
                <fpage>449</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">7912129</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.petruzzella.2004.64">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Petruzzella</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoccolella</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torraco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamberti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carnicella</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serlenga</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papa</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cerebellar ataxia as atypical manifestation of the 3243A&#x0003e;G MELAS mutation.</article-title>
                <source>Clin Genet</source>
                <volume>65</volume>
                <fpage>64</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15032978</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.ravn.2001.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ravn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>An mtDNA mutation, 14453G&#x02014;&#x0003e;A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>9</volume>
                <fpage>805</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11781695</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.rodriguez.2007.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parise</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beal</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.</article-title>
                <source>Muscle Nerve</source>
                <volume>35</volume>
                <fpage>235</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">17080429</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.sakuta.2002.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sakuta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honzawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murakami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Atypical MELAS associated with mitochondrial tRNA(Lys) gene A8296G mutation.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>27</volume>
                <fpage>397</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">12504210</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.santorelli.1997.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulikova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>238</volume>
                <fpage>326</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9299505</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.sato.1994.1055">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayasaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoji</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukawa</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wachi</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>A mitochondrial tRNA(Leu)(UUR) mutation at 3,256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).</article-title>
                <source>Biochem Mol Biol Int.</source>
                <year>1994</year>
                <volume>33</volume>
                <fpage>1055</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">7804130</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.scarpelli.2012">
              <mixed-citation publication-type="other">Scarpelli M, Zappini F, Filosto M, Russignan A, Tonin P, Tomelleri G. Mitochondrial Sensorineural Hearing Loss: A Retrospective Study and a Description of Cochlear Implantation in a MELAS Patient. Genet Res Int. 2012;2012:287432.</mixed-citation>
            </ref>
            <ref id="melas.REF.shanske.2004.134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pancrudo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>130A</volume>
                <fpage>134</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15372523</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.sparaco.1993.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sparaco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects.</article-title>
                <source>J Neuropathol Exp Neurol.</source>
                <volume>52</volume>
                <fpage>1</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8426185</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.sue.1998.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipsett</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crimmins</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsang</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyages</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Presgrave</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrne</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Cochlear origin of hearing loss in MELAS syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>43</volume>
                <fpage>350</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9506552</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.taivassalo.2004.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taivassalo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haller</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Implications of exercise training in mtDNA defects--use it or lose it?</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1659</volume>
                <fpage>221</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15576055</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.tam.2008.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tam</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feigenbaum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addis</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dosary</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel mitochondrial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis.</article-title>
                <source>Neuropediatrics</source>
                <volume>39</volume>
                <fpage>328</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19568996</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.tang.2013.882">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>VW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landsverk</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truong</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craigen</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects.</article-title>
                <source>Hum Mutat</source>
                <volume>34</volume>
                <fpage>882</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">23463613</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.tanji.2008.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willey</surname>
                    <given-names>JZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khandji</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel tRNA(Val) mitochondrial DNA mutation causing MELAS.</article-title>
                <source>J Neurol Sci</source>
                <volume>270</volume>
                <fpage>23</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18314141</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.taylor.1996.459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haldane</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA.</article-title>
                <source>Ann Neurol</source>
                <volume>40</volume>
                <fpage>459</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">8797538</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.treff.2012.1236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Treff</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferry</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>RT</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder.</article-title>
                <source>Fertil Steril.</source>
                <year>2012</year>
                <volume>98</volume>
                <fpage>1236</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">22921075</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.uusimaa.2004.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uusimaa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finnila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rantala</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainionpaa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassinen</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular epidemiology of childhood mitochondrial encephalomyopathies in a Finnish population: sequence analysis of entire mtDNA of 17 children reveals heteroplasmic mutations in tRNA<sup>Arg</sup>, tRNA<sup>Glu</sup>, and tRNA<sup>Leu(UUR)</sup> genes.</article-title>
                <source>Pediatrics</source>
                <volume>114</volume>
                <fpage>443</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15286228</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.wortmann.2007.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wortmann</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodenburg</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backx</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Early cardiac involvement in children carrying the A3243G mtDNA mutation.</article-title>
                <source>Acta Paediatr</source>
                <volume>96</volume>
                <fpage>450</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">17407476</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.yarham.2011.1319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yarham</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dosary</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alston</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations.</article-title>
                <source>Hum Mutat</source>
                <volume>32</volume>
                <fpage>1319</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">21882289</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.yasukawa.2000.4251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yasukawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.</article-title>
                <source>J Biol Chem</source>
                <volume>275</volume>
                <fpage>4251</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10660592</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.yatsuga.2012">
              <mixed-citation publication-type="other">Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, Kakuma T, Koga Y; Taro Matsuoka for MELAS Study Group in Japan. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619-24.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="melas.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="melas.Suggested_Reading.reflist0">
            <ref id="melas.REF.dimauro.2013.429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>The Clinical Maze of Mitochondrial Neurology.</article-title>
                <source>Nat Rev Neurol</source>
                <volume>9</volume>
                <fpage>429</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">23835535</pub-id>
              </element-citation>
            </ref>
            <ref id="melas.REF.klopstock.2012">
              <mixed-citation publication-type="webpage">Klopstock T, Hirano M. MELAS. In: Gilman S, ed-in-chief. <italic toggle="yes">Medlink Neurology</italic>. San Diego, CA: Medlink Corporation; 2012. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.medlink.com/medlinkcontent.asp?page=home">online</ext-link> (subscription required).</mixed-citation>
            </ref>
            <ref id="melas.REF.sproule.2008.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sproule</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>1142</volume>
                <fpage>133</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">18990125</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="melas.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="melas.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>21 November 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 October 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>13 October 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>18 June 2003 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>27 February 2001 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>September 2000 (sdm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
